Genomic Health, a life science company founded in August of 2000 and located in Redwood City, California, is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. To that end, the company conducts sophisticated genomic research to develop clinically-validated...
Networks
Gentium S.p.A. is a biopharmaceutical company focused on the research, discovery and development of drugs derived from DNA extracted from natural sources, and drugs that are synthetic derivatives, to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments. Defibrotide, the Company’s lead product...
Mit über 15.000 randomisierten Patienten ist die Deutsche Hodgkin Studiengruppe (GHSG) seit über 25 Jahren mit der Optimierung von Diagnostik, Therapie und Nachsorge betroffener Patienten befasst. Auf dieser Seite möchten wir über das Hodgkin Lymphom, die aktuellen Therapien und Aktivitäten der GHSG informieren. Dabei richten wir uns sowohl an Ärzte,...
To create funding to support research which is vital to the long-term survival of those coping with GIST. To provide patients and practitioners with more data on GIST. To provide information about GIST to the international community. To influence the U.S. Legislature in implementing policies towards coverage of oral drugs....
The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing institution that invests the world’s money to save lives. To date, it has committed US$ 19.3 billion in 144 countries to support large-scale prevention, treatment and care programs against the three diseases.
Global Genes® is one of the leading rare disease patient advocacy organizations in the world. The non-profit organization promotes the needs of the rare disease community under a unifying symbol of hope – the Blue Denim Genes Ribbon®. What began as a grassroots movement in 2009 , with just a...
The Glut1 Deficiency Foundation is a volunteer, non-profit family organization dedicated to: Educating others about Glut1 Deficiency by creating a forum for sharing support, experiences, resources, and information between patients, families, and healthcare professionals. Increasing awareness of and advocacy for Glut1 Deficiency. Supporting and funding researchers as they work for...
GlyGenix Therapeutics, Inc. is focused on treating and curing Glycogen Storage Disease Type 1a which is a heritable gene mutation that results in altered metabolic homeostasis. Our expertise in the application of UltraSound-mediated Plasmid DNA delivery (USP) will be unique and will provide a safe in vivo delivery approach for...
In 2013, Grace Wilsey was diagnosed with a rare genetic disorder called NGLY1 Deficiency. Her parents, Matt and Kristen, quickly discovered the incredible challenges they faced. At the time, Grace was one of only six known patients worldwide. Diseases that rare weren’t on the radars of big labs or pharmaceutical...
Great Ormond Street Hospital for Children, Search for medical conditions